Search research articles
Contact Us
Filters
Showing results (11-20 of 166) with videos related to
Page
of 17
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
June 1, 2014
The role of formulation on the pharmacokinetics of antiretroviral drugs
Diane E T Bastiaans, Tim R Cressey, Herman Vromans, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients
Tim R Cressey, Sawitree Nangola, Yardpiroon Tawon, et al.
The Pediatric Infectious Disease Journal
|
December 8, 2011
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
Wasana Prasitsuebsai, Tim R Cressey, Edmund Capparelli, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 30, 2015
Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults
Siwalee Rattanapunya, Tim R Cressey, Ronnatrai Rueangweerayut, et al.
Malaria Journal
|
October 11, 2015
Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults
Siwalee Rattanapunya, Tim R Cressey, Ronnatrai Rueangweerayut, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2025
Brief Report: Can a Fraction of the Dolutegravir Dispersible Tablet Solution be Used to Dose Neonates?
Cassius M Phogole, Adrie Bekker, Tim R Cressey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 1, 2006
Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy
Tim R Cressey, Prattana Leenasirimakul, Gonzague Jourdain, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2012
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
Kulkanya Chokephaibulkit, Maneeratn Nuntarukchaikul, Wanatpreeya Phongsamart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2020
Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)
Adrie Bekker, Eric H Decloedt, Gretchen Slade, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2020
Drug-drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment
Quanhathai Kaewpoowat, Romanee Chaiwarith, Saowaluck Yasri, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 166) with videos related to
Sort By:
Page
of 17
Expert Opinion on Drug Metabolism & Toxicology
|
June 1, 2014
The role of formulation on the pharmacokinetics of antiretroviral drugs
Diane E T Bastiaans, Tim R Cressey, Herman Vromans, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients
Tim R Cressey, Sawitree Nangola, Yardpiroon Tawon, et al.
The Pediatric Infectious Disease Journal
|
December 8, 2011
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
Wasana Prasitsuebsai, Tim R Cressey, Edmund Capparelli, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 30, 2015
Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults
Siwalee Rattanapunya, Tim R Cressey, Ronnatrai Rueangweerayut, et al.
Malaria Journal
|
October 11, 2015
Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults
Siwalee Rattanapunya, Tim R Cressey, Ronnatrai Rueangweerayut, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2025
Brief Report: Can a Fraction of the Dolutegravir Dispersible Tablet Solution be Used to Dose Neonates?
Cassius M Phogole, Adrie Bekker, Tim R Cressey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 1, 2006
Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy
Tim R Cressey, Prattana Leenasirimakul, Gonzague Jourdain, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2012
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
Kulkanya Chokephaibulkit, Maneeratn Nuntarukchaikul, Wanatpreeya Phongsamart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2020
Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)
Adrie Bekker, Eric H Decloedt, Gretchen Slade, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2020
Drug-drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment
Quanhathai Kaewpoowat, Romanee Chaiwarith, Saowaluck Yasri, et al.
Page
of 17